<DOC>
	<DOCNO>NCT02063581</DOCNO>
	<brief_summary>This Phase I , open-label , randomize , 2-period crossover study design determine relative bioavailability ipatasertib administer capsule tablet formulation healthy adult volunteer . Participants randomize one two treatment sequence receive single oral administration ipatasertib tablet capsule formulation follow , washout period , single oral administration ipatasertib second formulation . Pharmacokinetics assess , standard physical clinical evaluation perform throughout study . Time study expect 2 week .</brief_summary>
	<brief_title>A Study Evaluating Effect Formulation Bioavailability Ipatasertib Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male female volunteer age 18 55 year , inclusive Body mass index ( BMI ) 18.529.9 kg/m2 , inclusive Clinically significant finding medical history screening evaluation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>